5SL-10162-64482
3 vaccinations
5 coded responses
25 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 631 / MO
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-20
Registered in v-safe
-
2021-02-20
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Survey response — day 0, dose 1MedDRA: Dizziness, Visual impairment — Feeling: Good · Fatigue or tirednessFree text: Vision change / dizziness - only lasted about 2 minutesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-02-27
-
2021-03-13
Dose 2 — Pfizer-BioNTech
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-18
- 2021-03-19
- 2021-03-21
- 2021-04-04
- 2021-04-14
- 2021-04-17
-
2021-06-15
Survey response — 3 months, dose 2MedDRA: Pelvic organ prolapse — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pevlic ProlapseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-15
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-23
-
2021-06-28
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-09-11
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Health check-in — day 0, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-23
-
2021-12-24
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Swelling · HeadacheFree text: Lymph node swelling armpit same arm as injection site.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-26
- 2021-12-27
- 2021-12-29
- 2022-01-05
-
2022-01-12
Survey response — day 21, dose 3MedDRA: Headache — Feeling: FairFree text: Head achesMedDRA releases: 2024-11 · check-in free text available
- 2022-01-19
- 2022-01-28
-
2022-06-24
Survey response — 6 months, dose 3MedDRA: Back pain, COVID-19 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Covis 19 and Back pain aftwards that lasted about 2- 3 weeksMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-20 | Pfizer-BioNTech | |
| 2 | 2021-03-13 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-15 | Successful 2021-06-28 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Vision change / dizziness - only lasted about 2 minutes
Release 9 — 3 months, dose 2
Symptoms: Pevlic Prolapse
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node swelling armpit same arm as injection site.
Release 10 — day 21, dose 3
Symptoms: Head aches
Release 12 — 6 months, dose 3
Symptoms: Covis 19 and Back pain aftwards that lasted about 2- 3 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pelvic organ prolapse | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release